Abstract
The solution structure of the growth factor receptor-bound protein 2 (Grb2) SH2 domain complexed with a high-affinity inhibitor containing a non-phosphorus phosphate mimetic within a macrocyclic platform was determined by nuclear magnetic resonance (NMR) spectroscopy. Unambiguous assignments of the bound inhibitor and intermolecular NOEs between the Grb2 SH2 domain and the inhibitor was accomplished using perdeuterated Grb2 SH2 protein. The well-defined solution structure of the complex was obtained and compared to those by X-ray crystallography. Since the crystal structure of the Grb2 SH2 domain formed a domain-swapped dimer and several inhibitors were bound to a hinge region, there were appreciable differences between the solution and crystal structures. Based on the binding interactions between the inhibitor and the Grb2 SH2 domain in solution, we proposed a design of second-generation inhibitors that could be expected to have higher affinity.
Similar content being viewed by others
References
Breeze AL (2000) Isotope-filtered NMR methods for the study of biomolecular structure and interactions. Prog NMR Spectrosc 36:323–372
Buday L, Downward J (1993) Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor. Cell 73:611–620
Burke TR Jr (2006) Development of Grb2 SH2 domain signaling antagonists: a potential new class of antiproliferative agents. Int J Pept Res Therapeutics 12:33–48
Cornilescu G, Delaglio F, Bax A (1999) Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J Biomol NMR 13:289–302
Daly RJ, Binder MD, Sutherland RL (1994) Overexpression of the Grb2 gene in human breast cancer cell lines. Oncogene 9:2723–2727
Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6:277–293
Domchek SM, Auger KR, Chatterjee S, Burke TR Jr, Shoelson SE (1992) Inhibition of SH2 domain/phosphoprotein association by a nonhydrolyzable phosphonopeptide. Biochemistry 31:9865–9870
Eck MJ, Atwell SK, Shoelson SE, Harrison SC (1994) Structure of the regulatory domains of the Src-family tyrosine kinase Lck. Nature 368:764–769
Furet P, Gay B, Garcia-Echeverria C, Rahuel J, Fretz H, Schoepfer J, Caravatti G (1997) Discovery of 3-aminobenzyloxycarbonyl as an N-terminal group conferring high affinity to the minimal phosphopeptide sequence recognized by the Grb2-SH2 domain. J Med Chem 40:3551–3556
Furet P, Gay B, Caravatti G, Garcia-Echeverria C, Rahuel J, Schoepfer J, Fretz H (1998) Structure-based design and synthesis of high affinity tripeptide ligands of the Grb2-SH2 domain. J Med Chem 41:3442–3449
Furet P, Garcia-Echeverria C, Gay B, Schoepfer J, Zeller M, Rahuel J (1999) Structure-based design, synthesis, and X-ray crystallography of a high-affinity antagonist of the Grb2-SH2 domain containing an asparagine mimetic. J Med Chem 42:2358–2363
Gale NW, Kaplan D, Lowenstein EJ, Schlessinger J, Bar-Sagi D (1993) Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras. Nature 363:88–92
Gao Y, Voigt J, Wu JX, Yang D, Burke TR Jr (2001a) Macrocyclization in the design of a conformationally constrained Grb2 SH2 domain inhibitor. Bioorg Med Chem Lett 11:1889–1892
Gao Y, Wei CQ, Burke TR Jr (2001b) Olefin metathesis in the design and synthesis of a globally constrained Grb2 SH2 domain inhibitor. Org Lett 3:1617–1620
Garcia-Echeverria C, Furet P, Gay B, Fretz H, Rahuel J, Schoepfer J, Caravatti G (1998) Potent antagonists of the SH2 domain of Grb2: optimization of the X+1 position of 3-amino-Z-Tyr(PO3H2)-X+1-Asn-NH2. J Med Chem 41:1741–1744
Guntert P (2004) Automated NMR structure calculation with CYANA. Methods Mol Biol 278:353–378
Koradi R, Billeter M, Wuthrich K (1996) MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph 14:51–55
Kuriyan J, Cowburn D (1997) Modular peptide recognition domains in eukaryotic signaling. Annu Rev Biophys Biomol Struct 26:259–288
Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R, Thornton JM (1996) AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR 8:477–486
Li N, Batzer A, Daly R, Yajnik V, Skolnik E, Chadrin P, Bar-Sagi D, Margolis B, Schlessinger J (1993) Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature 363:85–88
Lowenstein EJ, Daly RJ, Batzer AG, Li W, Margolis B, Lammers R, Ullrich A, Skolnik EY, Bar-Sagi D, Schlessinger J (1992) The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 70:431–442
Marengere LE, Pawson T (1994) Structure and function of SH2 domains. J Cell Sci Suppl 18:97–104
Mikol V, Baumann G, Keller TH, Manning U, Zurini MG (1995) The crystal structures of the SH2 domain of p56lck complexed with two phosphonopeptides suggest a gated peptide binding site. J Mol Biol 246:344–355
Ogura K, Terasawa H, Inagaki F (1996) An improved double-tuned and isotope-filtered pulse scheme based on a pulsed field gradient and a wide-band inversion shaped pulse. J Biomol NMR 8:492–498
Ogura K, Tsuchiya S, Terasawa H, Yuzawa S, Hatanaka H, Mandiyan V, Schlessinger J, Inagaki F (1999) Solution structure of the SH2 domain of Grb2 complexed with the Shc-derived phosphotyrosine-containing peptide. J Mol Biol 289:439–445
Olejniczak ET, Xu RX, Fesik SW (1992) A 4D HCCH-TOCSY experiment for assigning the side chain 1H and 13C resonances of proteins. J Biomol NMR 2:655–659
Phan J, Shi ZD, Burke TR Jr, Waugh DS (2005) Crystal structures of a high-affinity macrocyclic peptide mimetic in complex with the Grb2 SH2 domain. J Mol Biol 353:104–115
Pronk GJ, de Vries-Smits AMM, Buday L, Downward J, Maassen JA, Medema RH, Bos JL (1994) Involvement of Shc in insulin- and epidermal growth factor-induced activation of p21ras. Mol Cell Biol 14:1575–1581
Rahuel J, Gay B, Erdmann D, Strauss A, Garcia-Echeverria C, Furet P, Caravatti G, Fretz H, Schoepfer J, Grutter MG (1996) Structural basis for specificity of GRB2-SH2 revealed by a novel ligand binding mode. Nat Struct Biol 3:586–589
Rozakis-Adcock M, McGlade J, Mbamalu G, Pelicci G, Daly R, Li W, Batzer A, Thomas S, Brugge J, Pelicci PG, Schlessinger J, Pawson T (1992) Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 360:689–692
Schlaepfer DD, Hanks SK, Hunter T, van der Geer P (1994) Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 372:786–791
Schwarz-Linek U, Werner JM, Pickford AR, Gurusiddappa S, Kim JH, Pilka ES, Briggs JA, Gough TS, Höök M, Campbell ID, Potts JR (2003) Pathogenic bacteria attach to human fibronectin through a tandem beta-zipper. Nature 423:177–181
Skolnik EY, Batzer A, Li N, Lee CH, Lowenstein LE, Mohammadi M, Margolis B, Schlessinger J (1993a) The function of GRB2 in linking the insulin receptor to Ras signaling pathways. Science 260:1953–1955
Skolnik EY, Lee CH, Batzer A, Vicentini LM, Zhou M, Daly R, Myers MJ Jr, Backer JM, Ullrich A, White MF, Schlessinger J (1993b) The SH2/SH3 domain-containing protein Grb2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signaling. EMBO J 12:1929–1936
Songyang Z, Shoelson SE, McGlade J, Olivier P, Pawson T, Bustelo XR, Barbacid M, Sabe H, Hanafusa H, Yi T, Ren R, Baltimore D, Ratnofsky S, Feldman RA, Cantley LC (1994) Specific motifs recognized by the SH2 domains of Csk, 3BP2, fes/fps, Grb-2, SHPTP1, SHC, Syk and Vav. Mol Cell Biol 14:2777–2785
Thornton KH, Mueller WT, McConnell P, Zhu G, Saltiel AR, Thanabal V (1996) Nuclear magnetic resonance solution structure of the growth factor receptor-bound protein 2 Src homology 2 domain. Biochemistry 35:11852–11864
Tsuchiya S, Ogura K, Hatanaka H, Nagata K, Terasawa H, Mandiyan V, Schlessinger J, Aimoto S, Ohta H, Inagaki F (1999) Solution structure of SH2 domain of Grb2/Ash complexed with EGF receptor derived phosphotyrosine containing peptide. J Biochem 125:1145–1153
Walters KJ, Matsuo H, Wagner G (1997) A simple method to distinguish intermonomer nuclear overhauser effects in homodimeric proteins with C 2 symmetry. J Am Chem Soc 119:5958–5959
Yip SS, Crew AJ, Gee JM, Hui R, Blamey RW, Robertson JF, Nicholson RI, Sutherland RL, Daly RJ (2000) Up-regulation of the protein tyrosine phosphatase SHP-1 in human breast cancer and correlation with GRB2 expression. Int J Cancer 88:363–368
Acknowledgement
This work was supported by Grant-in-Aid for Scientific Research and the National Projects on Protein Structure and Functional Analysis from the Ministry of Education, Science and Culture of Japan. This research was also supported in part by the International Research Program of the NIH, Center for Cancer Research, National Cancer Institute.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ogura, K., Shiga, T., Yokochi, M. et al. Solution structure of the Grb2 SH2 domain complexed with a high-affinity inhibitor. J Biomol NMR 42, 197–207 (2008). https://doi.org/10.1007/s10858-008-9272-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10858-008-9272-0